13.56
2.19%
0.29
시간 외 거래:
13.59
0.03
+0.22%
전일 마감가:
$13.27
열려 있는:
$13.36
하루 거래량:
143.84K
Relative Volume:
0.41
시가총액:
$568.68M
수익:
$150.71M
순이익/손실:
$-40.85M
주가수익비율:
-10.04
EPS:
-1.35
순현금흐름:
$-25.98M
1주 성능:
+7.96%
1개월 성능:
+3.43%
6개월 성능:
+0.22%
1년 성능:
-26.30%
Si Bone Inc Stock (SIBN) Company Profile
명칭
Si Bone Inc
전화
(408) 207-0700
주소
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
SIBN을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
SIBN
Si Bone Inc
|
13.56 | 568.68M | 150.71M | -40.85M | -25.98M | -1.01 |
ABT
Abbott Laboratories
|
118.77 | 206.00B | 41.22B | 5.77B | 6.49B | 3.29 |
SYK
Stryker Corp
|
392.15 | 149.49B | 21.97B | 3.59B | 3.21B | 9.33 |
BSX
Boston Scientific Corp
|
90.66 | 133.62B | 15.91B | 1.79B | 1.89B | 1.21 |
MDT
Medtronic Plc
|
86.54 | 110.97B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
71.35 | 42.08B | 6.60B | 4.16B | 490.10M | 6.93 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-08-06 | 재확인 | Needham | Buy |
2024-03-28 | 개시 | Piper Sandler | Overweight |
2022-10-12 | 개시 | Jefferies | Buy |
2022-04-07 | 재개 | Cantor Fitzgerald | Overweight |
2021-06-08 | 개시 | Citigroup | Buy |
2021-03-09 | 재확인 | Needham | Buy |
2020-12-16 | 재확인 | Needham | Buy |
2020-08-04 | 재확인 | Needham | Buy |
2020-06-16 | 재개 | Cantor Fitzgerald | Overweight |
2020-05-05 | 재확인 | Needham | Buy |
2020-02-19 | 개시 | Needham | Buy |
2020-01-08 | 개시 | SunTrust | Buy |
2019-12-18 | 개시 | Cantor Fitzgerald | Overweight |
2018-11-12 | 개시 | BofA/Merrill | Buy |
2018-11-12 | 개시 | Canaccord Genuity | Buy |
2018-11-12 | 개시 | JMP Securities | Mkt Outperform |
2018-11-12 | 개시 | Morgan Stanley | Overweight |
모두보기
Si Bone Inc 주식(SIBN)의 최신 뉴스
SI-BONE Inc (SIBN) Shares Up 2.75% on Nov 29 - GuruFocus.com
SI-BONE, Inc. (NASDAQ:SIBN) Sees Large Decline in Short Interest - MarketBeat
Wall Street Analysts See an 83.56% Upside in Si-Bone (SIBN): Can the Stock Really Move This High? - MSN
SI-BONE Inc (SIBN) Trading 3.4% Higher on Nov 27 - GuruFocus.com
Millrace Asset Group Inc. Buys Shares of 75,542 SI-BONE, Inc. (NASDAQ:SIBN) - MarketBeat
SI-BONE's SWOT analysis: medical device maker's stock poised for growth - Investing.com
SI-BONE, Inc. (NASDAQ:SIBN) Shares Bought by Champlain Investment Partners LLC - MarketBeat
SI-BONE (NASDAQ:SIBN) Earns Buy Rating from Needham & Company LLC - Defense World
SI-BONE, Inc. (NASDAQ:SIBN) Receives $23.00 Average Target Price from Brokerages - MarketBeat
Si Bone stock hits 52-week low at $11.75 amid market challenges - Investing.com Australia
SI-BONE (NASDAQ:SIBN) Hits New 52-Week Low After Insider Selling - Defense World
Si Bone stock hits 52-week low at $11.75 amid market challenges By Investing.com - Investing.com South Africa
Si-Bone CEO Laura Francis sells $126,353 in common stock By Investing.com - Investing.com Australia
Si-Bone CEO Laura Francis sells $126,353 in common stock - Investing.com India
Needham sees buying opportunity for SI-BONE stock amid recent weakness By Investing.com - Investing.com South Africa
Si-Bone CFO Anshul Maheshwari sells $30,936 in stock By Investing.com - Investing.com Canada
Si-Bone's president sells shares valued at $74,802 By Investing.com - Investing.com South Africa
Si-Bone director Jeffrey W. Dunn sells shares worth $20,001 By Investing.com - Investing.com South Africa
Si-Bone director Jeffrey W. Dunn sells shares worth $20,001 - Investing.com
Si-Bone CFO Anshul Maheshwari sells $30,936 in stock - Investing.com
SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024 - The Manila Times
SI-BONE to Present at Piper Sandler Healthcare Conference in December | SIBN Stock News - StockTitan
Needham & Company LLC Reiterates "Buy" Rating for SI-BONE (NASDAQ:SIBN) - MarketBeat
Needham sees buying opportunity for SI-BONE stock amid recent weakness - Investing.com
The Analyst Verdict: SI-BONE In The Eyes Of 4 Experts - Benzinga
Cantor Fitzgerald Boosts Earnings Estimates for SI-BONE - Defense World
Cantor Fitzgerald Increases Earnings Estimates for SI-BONE - MarketBeat
SI-BONE (NASDAQ:SIBN) Price Target Raised to $18.00 at Truist Financial - Defense World
SI-BONE (NASDAQ:SIBN) Trading Up 3.9%Here's What Happened - MarketBeat
Impax Asset Management Group plc Acquires 221,604 Shares of SI-BONE, Inc. (NASDAQ:SIBN) - MarketBeat
Analysis of First Light Asset Management's Recent Reduction in S - GuruFocus.com
SI-BONE, Inc. (NASDAQ:SIBN) Just Released Its Third-Quarter Earnings: Here's What Analysts Think - Yahoo Finance
How to Take Advantage of moves in (SIBN) - Stock Traders Daily
SI-BONE Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Santa Clara company's hip fracture tech gains momentum - The Business Journals
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance - OrthoSpineNews
Needham & Company LLC Reaffirms Buy Rating for SI-BONE (NASDAQ:SIBN) - MarketBeat
SI-BONE, Inc. (NASDAQ:SIBN) Q3 2024 Earnings Call Transcript - Insider Monkey
SI-BONE posts USD 40.3M revenue, a 19% increase in Q3 2024 - Medical Buyer
Si-Bone: Q3 Earnings Snapshot - CT Insider
SI-BONE Inc (SIBN) Q3 2024 Earnings Call Highlights: Record Reve - GuruFocus.com
SI-BONE Inc (SIBN) Q3 2024 Earnings Call Highlights: Record Revenue and Path to Profitability - Yahoo Finance
SI-BONE Reports Strong Q3 Growth and Optimistic Outlook - TipRanks
Si-Bone (SIBN) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
SI-BONE Inc Reports Q3 2024 Revenue of $40.3M and EPS of -$0.16, Slightly Missing Estimates - GuruFocus.com
Si-Bone earnings beat by $0.08, revenue fell short of estimates - Investing.com UK
SI-BONE Q3 Revenue Surges 19% to $40.3M, Slashes EBITDA Loss by 94% | SIBN Stock News - StockTitan
SI-BONE Inc (SIBN) Q3 2024 Earnings Report Preview: What To Look For - GuruFocus.com
SI-BONE (SIBN) Set to Announce Quarterly Earnings on Tuesday - Defense World
Si-Bone director Jeffrey Dunn sells $4,620 in common stock - Investing.com
Si Bone Inc (SIBN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):